Catalent Inc

Catalent Inc., incorporated in 2007, is a global provider of development and manufacturing solutions for the pharmaceutical and biotechnology industries. With its headquarters situated in Somerset, New Jersey, United States, the company excels in a range of business segments, including Biologics, Softgel and Oral Technologies, Oral and Specialty Delivery, and Clinical Supply Services. The Biologics segment delivers comprehensive services such as drug substance and product development, cell line and bio-conjugate development, along with biologic drug formulation. In Softgel and Oral Technologies, Catalent is an expert in softgel formulations for various delivery routes and provides innovative oral delivery solutions like fast-dissolve tablets. The Oral and Specialty Delivery segment is centered on cutting-edge drug delivery technologies. Products include oral disintegrating tablets, controlled release formulations, and targeted specialty oral delivery methods. Meanwhile, Clinical Supply Services encompasses a broad suite of services related to the clinical trial supply chain management, offering packaging, storage, distribution, and inventory management. Rather than developing consumer-facing brands, Catalent's strengths are in its proprietary technology platforms and services. Notable among these are Zydis for fast-dissolve tablet technology, SMARTag for antibody-drug conjugate (ADC) technology, and the OptiForm solution suite for drug development. Catalent's operations span across numerous countries, with a notable presence in the United States, United Kingdom, Germany, Belgium, France, China, and Japan. These locations are strategically vital for its extensive product and service offerings in the dynamic sectors of pharmaceuticals and biotechnology. (Powered by AI)